Fall Course 2022

November 17-20, 2022
DoubleTree Hilton Hotel
Scottsdale, AZ - USA

Local Time: 06:57 am


Learner Notification

International Society for the Study of Women's Sexual Health
2022 Vulvoscopy Course
November 20, 2022
Scottsdale, AZ

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity. 

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

Joint Accreditation Statement

Jointly Accredited Provider ISSWSH
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women's Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)
Amedco LLC designates this live activity for a maximum of 4.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This program meets the requirements of the American Association of Sexuality Educators, Counselors and Therapists (AASECT) and is approved for 4.5 AASECT CE Credits. These CE Credits may be applied toward AASECT certification and renewal of certification.

Objectives - After Attending This Program You Should Be Able To

  1. Develop skills that allow for discussing sexual concerns with female patients.
  2. Cite the pathophysiology of hormonal, vascular and neurologic causes of sexual dysfunction in women.
  3. Describe the specific assessment for sexual dysfunction related to psychosexual factors.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below. 



Commercial Interest






AbbVie:Research Grant Site Principal Investigator,Cynosure:Consultant,TRT:Speakers Bureau,Clarus:Speakers Bureau,Sprout:Consultant,TGI:Research Grant Site Principal Investigator,Solv Wellness:Research Grant Site Principal Investigator,Coloplast:Speakers Bureau,Endo:Scientific/Medical Advisory Board Member,SST:Research Grant Site Principal Investigator



Cynosure:Consultant,Solv Wellness:Consultant

Crista Elcira





Materna:Consultant,Scynexis:Scientific/Medical Advisory Board Member,Good Clean Love:Scientific/Medical Advisory Board Member,Lupin:Scientific/Medical Advisory Board Member,Bonafide:Scientific/Medical Advisory Board Member,Dare:Consultant,Mystery Vibe:Consultant



Astellas:Consultant,Field Trip:Stock Shareholder,Field Trip:Consultant,Palatin Technologies, Inc.:Consultant,Pfizer, Lupin, Materna:Consultant,Dare:Research Grant Site Principal Investigator,dare:Consultant,TherapeuticsMD:Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Materna Medical:Stock Shareholder,Strategic Science Technologies:Consultant



Astellas, Bayer:Consultant,Field Trip, Alloy, Ms. Medicine, Viveve:Stock Shareholder,Field Trip:Consultant,Palatin Technologies, Inc.:Consultant,Pfizer, Materna:Consultant,Dare:Research Grant Site Principal Investigator,dare:Consultant,TherapeuticsMD:Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Materna Medical:Stock Shareholder,Strategic Science Technologies:Consultant



Dare Bioscience:Consultant,Ms. Medicine Provider Executive Group:Consultant,Roman Health Adventures:Consultant






Sprout:Consultant,Absorption Pharmaceuticals:Scientific/Medical Advisory Board Member






Bayer Healthcare, Besins Healthcare, California Institute of Integral Studies (CIIS), Dare Bioscience, DEKA M.E.L.A S.r.l., Femasys, KaNDy/NeRRe Therapeutics, Khyria, Madorra:Consultant,Mitsubishi Tanabe Pharma Development America, QUE Oncology, Scynexis Inc, Sprout Pharmaceuticals, Vella Bioscience:Consultant,Mayne Pharma, Myovant Sciences, Pfizer, Pharmavite, Scynexis, TherapeuticsMD.:Speakers Bureau,Sermonix Pharmaceuticals:Stock Shareholder,AbbVie, Bayer Healthcare, DareBioscience, Enteris BioPharma, Mylan/Viatris, Myovant Sciences, ObsEva, Viveve Medical:Research Grant Overall Principal Investigator


Save The Date

ISSWSH Genitopelvic Pain Course 2022-2023
Multiple Dates
More Information

ISSWSH Annual Meeting 2023
March 2-5, 2023   -22 days left
Marriott St. Louis Grand - St. Louis, MO
Visit the Meeting Website

ISSWSH Fall Course 2023
October 19-22, 2023   209 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ

ISSWSH Annual Meeting 2024
February 22-25, 2024   335 days left
Hyatt Regency Long Beach - Long Beach, CA
Visit the Meeting Website

Latest Tweets

Lichen sclerosus is a common inflammatory disorder that affects the skin in the areas of the anus and genitals. Che… https://t.co/jmvywGpv7G ISSWSH
At the 2023 ISSWSH Annual Meeting, those who provided outstanding service were recognized. Thank you to Jewel Kling… https://t.co/5LdD5HfoMc ISSWSH
Are you sleeping enough? Do you have issues falling asleep or staying asleep? It’s easy to forget how important sle… https://t.co/OrfGCj8dw5 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram